MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN)

277 filings reported holding MYGN - MYRIAD GENETICS INC - Common Stock, par value $0.01 per share as of Q4 2024.
MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) has 215 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 92.4M shares of 93.1M outstanding shares and own 99.21% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (15.9M shares), VANGUARD GROUP INC (10.6M shares), WELLINGTON MANAGEMENT GROUP LLP (6M shares), STATE STREET CORP (5.53M shares), MILLENNIUM MANAGEMENT LLC (4.35M shares), GLENVIEW CAPITAL MANAGEMENT, LLC (4.16M shares), EARNEST PARTNERS LLC (3.97M shares), Camber Capital Management LP (3.1M shares), Artisan Partners Limited Partnership (2.77M shares), and DISCIPLINED GROWTH INVESTORS INC /MN (2.56M shares).
This table shows the top 215 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.